Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of AZD9567 in Healthy Men
NCT02512575Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of mizacorat in rheumatoid arthritis (RA) (3 arms), sponsored by AstraZeneca. Primary endpoints: Number of Participants With Adverse Events, Maximum Plasma Concentration and 3 more. Started Nov 2015; status: completed.
02
Drugs
mizacorat
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02512575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02512575.